Canada markets closed

GRTS Aug 2022 17.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 01:47PM EDT. Market open.
Full screen
Previous Close0.0500
Open0.0500
Bid0.0000
Ask0.2500
Strike17.50
Expire Date2022-08-19
Day's Range0.0500 - 0.0500
Contract RangeN/A
Volume1
Open Interest94
  • GlobeNewswire

    Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update

    -- Clinical programs continue to progress, with initial data from Phase 2 study of “off the shelf” SLATE-KRAS and multiple studies within T cell-enhanced SARS-CoV-2 program (CORAL) expected this year -- -- Follow up data from subset of CORAL-BOOST study shows strong neutralizing antibody titers persisted without decay for at least 6 months after single boost administration of self-amplifying mRNA (samRNA) -- -- New credit facility provides financial flexibility entering period of multiple potent

  • Simply Wall St.

    Investors in Gritstone bio (NASDAQ:GRTS) have unfortunately lost 73% over the last three years

    As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an...

  • GlobeNewswire

    Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    EMERYVILLE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company’s Board of Directors has granted three employees nonqualified stock options to purchase an aggregate of 29,200 shares of its common stock with an exercise price of $2.68, which is equal to the closing price of Gritstone’s common stock on July 15, 2022, the last trading day preceding